Zantac and Paroxetine drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Zantac and Paroxetine. Common interactions include nausea among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people who take Zantac and Paroxetine have. It is created by eHealthMe based on reports of 500 people who take Zantac and Paroxetine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
500 people who take Zantac and Paroxetine together, and have interactions are studied.
What is Zantac?
Zantac has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 216,074 Zantac users for its effectiveness, alternative drugs and more.
What is Paroxetine?
Paroxetine has active ingredients of paroxetine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 54,051 Paroxetine users for its effectiveness, alternative drugs and more.
Number of Zantac and Paroxetine reports submitted per year:
Zantac and Paroxetine drug interactions by gender *:
Zantac and Paroxetine drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Zantac and Paroxetine?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
Alternative drugs to, pros and cons of the 2 drugs:
Common Zantac and Paroxetine interactions:
- Anoxic encephalopathy (brain damage due to lack of oxygen): 7 reports
- Cardiomegaly (increased size of heart than normal): 23 reports
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture): 25 reports
- Cva: 25 reports
- Enlarged heart: 23 reports
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 25 reports
Browse all drug interactions of Zantac and Paroxetine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Zantac interactions:
Browse all interactions between Zantac and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Paroxetine interactions:
Browse all interactions between Paroxetine and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on ranitidine hydrochloride and paroxetine hydrochloride (the active ingredients of Zantac and Paroxetine, respectively), and Zantac and Paroxetine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.